MedEase: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MedEase
Largest movements
- Receivables within one year +€2,499
new in 2025: €2,499
of which Other amounts receivable: +€1,524
- Cash +€1,563
up €1,563 (+41.5%), from €3,767 to €5,330
mainly Net result for the year (+€3,457) and Other debts (+€471)
- Reserves +€1,775
new in 2025: €1,775
- Profit (loss) carried forward +€1,683
up €1,683, from -€1,683 to €0
- Other debts +€471
up €471 (+263.6%), from €179 to €650
- Tax, wage and social debts +€305
up €305 (+154.1%), from €198 to €504
- Trade debts -€151
down €151 (-100.0%), from €151 to €0
- Gross operating margin +€5,673
up €5,673, from -€1,609 to €4,064
- Taxes +€504
new in 2025: €504
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €3,845 | €7,928 | +€4,083 | +106.2% |
| Current assets | 29/58 | €3,845 | €7,928 | +€4,083 | +106.2% |
| Amounts receivable within one year | 40/41 | - | €2,499 | +€2,499 | |
| Trade receivables | 40 | - | €975 | +€975 | |
| Other amounts receivable | 41 | - | €1,524 | +€1,524 | |
| Cash at bank and in hand | 54/58 | €3,767 | €5,330 | +€1,563 | +41.5% |
| Deferred charges and accrued income | 490/1 | €78 | €99 | +€21 | +26.8% |
| Total equity and liabilities | 10/49 | €3,845 | €7,928 | +€4,083 | +106.2% |
| Equity | 10/15 | €3,317 | €6,775 | +€3,457 | +104.2% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Reserves | 13 | - | €1,775 | +€1,775 | |
| Distributable reserves | 133 | - | €1,775 | +€1,775 | |
| Profit (loss) carried forward | 14 | -€1,683 | €0 | +€1,683 | |
| Amounts payable | 17/49 | €528 | €1,153 | +€625 | +118.4% |
| Amounts payable within one year | 42/48 | €528 | €1,153 | +€625 | +118.4% |
| Trade debts | 44 | €151 | €0 | -€151 | -100.0% |
| Suppliers | 440/4 | €151 | €0 | -€151 | -100.0% |
| Taxes, remuneration and social security | 45 | €198 | €504 | +€305 | +154.1% |
| Taxes | 450/3 | €198 | €504 | +€305 | +154.1% |
| Other amounts payable | 47/48 | €179 | €650 | +€471 | +263.6% |
| Other operating charges | 640/8 | €50 | €62 | +€12 | +24.0% |
| Gross operating margin | 9900 | -€1,609 | €4,064 | +€5,673 | |
| Operating profit (loss) | 9901 | -€1,659 | €4,002 | +€5,661 | |
| Financial charges | 65/66B | €24 | €41 | +€17 | +73.5% |
| Recurring financial charges | 65 | €24 | €41 | +€17 | +73.5% |
| Profit (loss) for the period before taxes | 9903 | -€1,683 | €3,961 | +€5,644 | |
| Income taxes | 67/77 | - | €504 | +€504 | |
| Profit (loss) for the period | 9904 | -€1,683 | €3,457 | +€5,140 | |
| Profit (loss) for the period to be appropriated | 9905 | -€1,683 | €3,457 | +€5,140 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.